Technical Analysis for ADMA - ADMA Biologics Inc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Multiple of Ten Bullish | Other | 3.59% | |
Wide Bands | Range Expansion | 3.59% | |
NR7 | Range Contraction | 9.37% | |
Wide Bands | Range Expansion | 9.37% | |
Multiple of Ten Bearish | Other | 12.24% | |
Wide Bands | Range Expansion | 12.24% | |
Down 3 Days in a Row | Weakness | 12.24% | |
Down 4 Days in a Row | Weakness | 12.24% |
Alert | Time |
---|---|
Up 3% | about 20 hours ago |
60 Minute Opening Range Breakout | about 23 hours ago |
Rose Above 10 DMA | about 23 hours ago |
Up 2% | about 23 hours ago |
Up 1% | about 23 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. RI-002 is an injectable immune globulin derived from human plasma enriched with high levels of naturally occurring polyclonal antibodies, as well as high levels of antibodies targeted to respiratory syncytial virus. The company also operates ADMA BioCenters, which are plasma collection centers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Biology Immunology Immune System Infectious Diseases Antibodies IBD 50 Antibody Glycoproteins Polyclonal Antibodies
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Biology Immunology Immune System Infectious Diseases Antibodies IBD 50 Antibody Glycoproteins Polyclonal Antibodies
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 23.64 |
52 Week Low | 3.6 |
Average Volume | 5,516,560 |
200-Day Moving Average | 12.09 |
50-Day Moving Average | 18.72 |
20-Day Moving Average | 19.20 |
10-Day Moving Average | 20.89 |
Average True Range | 1.13 |
RSI (14) | 60.94 |
ADX | 32.26 |
+DI | 38.69 |
-DI | 21.46 |
Chandelier Exit (Long, 3 ATRs) | 20.24 |
Chandelier Exit (Short, 3 ATRs) | 18.74 |
Upper Bollinger Bands | 23.49 |
Lower Bollinger Band | 14.91 |
Percent B (%b) | 0.75 |
BandWidth | 44.69 |
MACD Line | 0.84 |
MACD Signal Line | 0.74 |
MACD Histogram | 0.0963 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 22.76 | ||||
Resistance 3 (R3) | 22.61 | 22.00 | 22.53 | ||
Resistance 2 (R2) | 22.00 | 21.65 | 22.08 | 22.45 | |
Resistance 1 (R1) | 21.69 | 21.43 | 21.85 | 21.83 | 22.37 |
Pivot Point | 21.08 | 21.08 | 21.16 | 21.15 | 21.08 |
Support 1 (S1) | 20.76 | 20.72 | 20.92 | 20.91 | 20.37 |
Support 2 (S2) | 20.15 | 20.51 | 20.23 | 20.29 | |
Support 3 (S3) | 19.84 | 20.15 | 20.21 | ||
Support 4 (S4) | 19.98 |